Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000315066-15-003184
Filing Date
2015-10-14
Accepted
2015-10-14 15:14:36
Documents
1

Document Format Files

Seq Description Document Type Size
1 ACLARIS 13G 20151023_5385670713GFMR96571.txt SC 13G 7902
  Complete submission text file 0000315066-15-003184.txt   9440
Mailing Address 245 SUMMER STREET BOSTON MA 02210
Business Address 245 SUMMER STREET BOSTON MA 02210 6175706339
FMR LLC (Filed by) CIK: 0000315066 (see all company filings)

EIN.: 043532603 | Fiscal Year End: 1231
Type: SC 13G
SIC: 0000

Mailing Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355
Business Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355 484-321-5554
Aclaris Therapeutics, Inc. (Subject) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89137 | Film No.: 151158170
SIC: 2834 Pharmaceutical Preparations